Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
73.17
+1.10 (1.53%)
Jun 24, 2025, 12:50 PM - Market open

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 2013 - 2020
Plasma Products and Services
-
Log In
Log In
Log In
Log In
Upgrade
Plasma Products and Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Blood Center Products and Services
-
Log In
Log In
Log In
Log In
Upgrade
Blood Center Products and Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Products and Services
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Products and Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Plasma
535.43M
Log In
Log In
Log In
Log In
Upgrade
Plasma Growth
-5.99%
Log In
Log In
Log In
Log In
Upgrade
Blood Center
261.12M
Log In
Log In
Log In
Log In
Upgrade
Blood Center Growth
-7.81%
Log In
Log In
Log In
Log In
Upgrade
Hospital
564.27M
Log In
Log In
Log In
Log In
Upgrade
Hospital Growth
23.66%
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Effect of Exchange Rates on
-
Log In
Log In
Log In
Log In
Upgrade
Effect of Exchange Rates on Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 2013 - 2020
Plasma Segment Operating Income (Post-Q3 2025 Reporting)
184.51M
Log In
Log In
Log In
Log In
Upgrade
Plasma Segment Operating Income (Post-Q3 2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)
52.82M
Log In
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income (Post-Q3 2025 Reporting)
88.98M
Log In
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income (Post-Q3 2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Plasma Segment Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Plasma Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 2013 - 2020
United States
1.01B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
4.22%
Log In
Log In
Log In
Log In
Upgrade
Japan
62.41M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
7.44%
Log In
Log In
Log In
Log In
Upgrade
Europe
175.66M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
9.69%
Log In
Log In
Log In
Log In
Upgrade
Asia
92.31M
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-14.16%
Log In
Log In
Log In
Log In
Upgrade
Other Geographic
19.54M
Log In
Log In
Log In
Log In
Upgrade
Other Geographic Growth
47.09%
Log In
Log In
Log In
Log In
Upgrade